VAUGHAN, Ontario, January 02, 2026--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb" or the "company"), a leading global eye health company dedicated to helping people see ...
VAUGHAN, Ontario — Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “company”), a leading global eye health company dedicated to helping people see better to live better, today ...
Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “company”), a leading global eye health company dedicated to helping people see better to live better, today announced that it closed ...
Bausch + Lomb is taking out roughly $2.8 billion in new loans to refinance its debt. The eye health company, a subsidy of Bausch Health Cos., said Friday that it was amending its credit agreement to ...
Bausch + Lomb to launch fifth annual fundraising challenge during Glaucoma Awareness Month in partnership with Glaucoma Research Foundation, with all proceeds supporting glaucoma research Bausch + ...
Hosted on MSN
Evercore ISI Group downgrades Bausch + Lomb (BLCO)
Fintel reports that on January 5, 2026, Evercore ISI Group downgraded their outlook for Bausch + Lomb (NYSE:BLCO) from Outperform to In-Line. Analyst Price Forecast Suggests 4.58% Upside As of ...
Is launching its fifth annual fundraising challenge with Glaucoma Research Foundation (GRF) during Glaucoma Awareness Month in January. Bausch + Lomb will also sponsor The Glaucoma Foundation’s (TGF) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback